Literature DB >> 8415628

A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1.

Z Y Wang1, Q Q Qiu, K T Enger, T F Deuel.   

Abstract

The putative Wilms tumor suppressor gene, wt1, encodes a zinc-finger protein that binds to the DNA sequence 5'-GCGGGGGCG-3'. We previously reported that WT1 has separable domains that function either to activate or suppress transcription. We now have identified a second WT1 binding sequence (5'-TCCTCCTCCTCCTCTCC-3') 3' to the transcription initiation site of the platelet-derived growth factor A-chain gene by DNase I footprinting and gel mobility shift assays. WT1 requires both 5' and 3' binding sites for transcriptional suppression; however, WT1 functions as a transcriptional activator when it binds to either the 5' or 3' site alone. This second WT1 binding sequence functions equally well as the previously identified 5'-GCGGGGGCG-3' sequence when analyzed in transient transfection assays. A core DNA sequence recognized by WT1 was defined by using related synthetic oligonucleotides. We also identified sequences similar to the WT1 binding site within the promoter regions of five other growth-related genes and demonstrated that each of these sequences also binds WT1 in gel mobility shift assays. These results thus identify a second WT1 binding site and suggest that additional growth-related genes may be transcriptionally influenced by WT1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415628      PMCID: PMC47467          DOI: 10.1073/pnas.90.19.8896

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease.

Authors:  A C Johnson; Y Jinno; G T Merlino
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Structure of the human insulin receptor gene and characterization of its promoter.

Authors:  S Seino; M Seino; S Nishi; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.

Authors:  G E Fraizer; D F Bowen-Pope; A M Vogel
Journal:  J Cell Physiol       Date:  1987-10       Impact factor: 6.384

5.  A cis-acting transcription element of the c-myc gene can assume an H-DNA conformation.

Authors:  A J Kinniburgh
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 7.  Polypeptide growth factors: roles in normal and abnormal cell growth.

Authors:  T F Deuel
Journal:  Annu Rev Cell Biol       Date:  1987

8.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

10.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.

Authors:  M Gessler; A Poustka; W Cavenee; R L Neve; S H Orkin; G A Bruns
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

View more
  31 in total

1.  Analysis of WT1 gene expression during mouse nephrogenesis in organ culture.

Authors:  H Yeger; D Forget; J Alami; B R Williams
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

2.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

3.  Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target.

Authors:  Mohammad Shahidul Makki; E Cristy Ruteshouser; Vicki Huff
Journal:  Exp Cell Res       Date:  2013-01-02       Impact factor: 3.905

4.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Expression and function of the leucine zipper protein Par-4 in apoptosis.

Authors:  S F Sells; S S Han; S Muthukkumar; N Maddiwar; R Johnstone; E Boghaert; D Gillis; G Liu; P Nair; S Monnig; P Collini; M P Mattson; V P Sukhatme; S G Zimmer; D P Wood; J W McRoberts; Y Shi; V M Rangnekar
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Authors:  Maike Busch; Heinrich Schwindt; Artur Brandt; Manfred Beier; Nicole Görldt; Paul Romaniuk; Eneda Toska; Stefan Roberts; Hans-Dieter Royer; Brigitte Royer-Pokora
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

Review 7.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

8.  Modification of EWS/WT1 functional properties by phosphorylation.

Authors:  J Kim; J M Lee; P E Branton; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

9.  The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.

Authors:  Dagmar Wilhelm; Christoph Englert
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

10.  The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy.

Authors:  Lesley A Simpson; Emily A Burwell; Kida A Thompson; Samira Shahnaz; Allen R Chen; David M Loeb
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.